Xin Lang Cai Jing·2025-10-11 01:46Core Viewpoint - The trademark dispute over "Wanglaoji" between JDB Group and Guangzhou Wanglaoji Health Industry Co., Ltd. has intensified, with both parties asserting their claims regarding overseas trademark ownership and registration [3][4]. Group 1: Trademark Dispute - JDB Group claims to have obtained the overseas trademark rights for "Wanglaoji" in the early 2000s and has registered the trademark in 60 countries [3]. - Guangzhou Wanglaoji Health Industry Co., Ltd. asserts that the current trademark owner is Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., and they have registered "Wanglaoji" in over 100 countries [4]. - The ongoing dispute has seen legal actions, including a recent court ruling that found JDB Group liable for infringement, resulting in a compensation order of 317 million yuan [4]. Group 2: Market Position and Strategy - As of June 2025, Wanglaoji holds a 46.33% market share in the plant beverage category, while JDB follows with 28.31% [4]. - Wanglaoji is expanding its international market presence with new product launches and partnerships, including the introduction of "WALOVI" branded cans in various international markets [5]. - The company reported a revenue of 6.499 billion yuan in the first half of 2025, reflecting an 8.38% year-on-year growth [5]. Group 3: Industry Growth - The global plant beverage industry is experiencing rapid growth, with a compound annual growth rate of nearly 10% projected from 2019 to 2024, particularly in emerging markets like Southeast Asia and the Middle East [6].